If you follow K-beauty outside Korea, COSRX can feel almost unavoidable.
The Advanced Snail 96 Mucin Power Essence, the Low pH Good Morning Gel Cleanser and the brand’s acne patches have been recommended for years across Amazon, TikTok, Reddit and international beauty retailers.
For many shoppers, COSRX is not just another Korean skincare brand. It is one of the brands that helped define K-beauty abroad.
So here is the question I keep asking on this site:
Is COSRX actually popular in Korea too?
The answer is more complicated than a simple yes or no.
Yes, COSRX is a real Korean brand that Korean shoppers can and do buy. It has been sold domestically for years, is available through major Korean retailers and has accumulated a substantial history of Korean consumer reviews.
But there is another number that changes how you should understand the brand:
More than 90% of COSRX’s sales come from outside Korea.
And that is not the story of a Korean brand that failed at home and had to look overseas.
Going global was the plan from the beginning.
COSRX was built with overseas markets in mind
COSRX took an unusual route.
According to Korean business reporting based on the company’s own account, founder Jeon Sang-hoon spent years in the cosmetics industry with a specific goal: to create a brand that could work better outside Korea than inside it.
He founded COSRX in 2013 with that idea.
Rather than focusing first on winning domestic shelf space and then expanding abroad, COSRX moved early onto global e-commerce platforms including Amazon and eBay.
That decision became central to the way the company developed products too.
In its early years, COSRX employees translated and analyzed reviews from international customers themselves. Those reviews were not treated simply as feedback after a product launched. The company used them to understand what overseas consumers wanted and fed those findings back into product development.
COSRX formalized that approach over time.
It established a dedicated R&D organization called RX Lab in 2017 and developed its own consumer review analysis platform in 2022.
The scale eventually became much larger than manually reading customer comments.
For the RX line, COSRX collected and analyzed more than four million reviews across 34 countries, 60 languages and 134 distribution platforms.
The line passed 10 million cumulative units sold in December 2024, roughly two years after launch.
Today, COSRX sells in around 140 countries, and overseas markets account for more than 90% of its total revenue.
That number reframes the original question.
COSRX is not simply a Korean bestseller that was exported successfully. It is a Korean company that built an export business from the beginning.
But COSRX is not an “export-only” brand either
That does not mean Korean consumers do not use COSRX.
The brand is readily available in Korea through major domestic channels including Olive Young, Naver and Coupang.
It also has a long history on Korean beauty review platforms.
On Hwahae, older products such as the AHA/BHA Clarifying Treatment Toner have accumulated tens of thousands of consumer reviews over time, while newer peptide, vitamin C and retinol products have developed Korean review histories of their own.
That is not what an overseas-only brand looks like.
COSRX has a genuine domestic customer base built over more than a decade.
But there is an important distinction between being used in Korea and being one of the brands that defines the Korean skincare market.
The first is easy to establish for COSRX.
The second is much harder.
And that distinction is why simply asking whether a K-beauty brand is “popular in Korea” can be misleading.
The bigger surprise is what happened to snail mucin
Ask an international skincare shopper to name one COSRX product and there is a good chance the answer will be the Advanced Snail 96 Mucin Power Essence.
The Snail line became one of COSRX’s defining global franchises and was central to the company’s growth for years.
But it is no longer its largest product line.
According to KB Securities, the RX line grew to the mid-30% range of total COSRX sales in the first quarter of 2026, overtaking the Snail line.
The same analyst report estimated that the United States alone accounted for roughly 40% of COSRX sales.
These are analyst estimates rather than figures separately disclosed by Amorepacific, so I would not treat them as company-reported numbers.
But the broader direction is supported by COSRX itself.
COSRX itself pointed to a broader mix of growth drivers in mid-2026, highlighting continued strength of its Snail Line in the US alongside rapid growth of its Peptide Eye Patch and strong performance from the Ultra-Light Invisible Sun Serum in Europe.
That distinction matters.
The analyst estimate tells us how large RX may have become.
The company’s own update shows that its current growth is no longer coming from Snail alone.
So the international image of COSRX and the business underneath it are no longer exactly the same.
The numbers behind COSRX’s rise
The speed of COSRX’s growth becomes clearer when you look at its revenue.
| Year | COSRX revenue |
|---|---|
| 2021 | KRW 123.3 billion |
| 2022 | KRW 204.4 billion |
| 2023 | KRW 486.2 billion |
| 2024 | KRW 589.9 billion |
| 2025 | KRW 456.3 billion |
COSRX went from KRW 123.3 billion in revenue in 2021 to nearly KRW 590 billion only three years later.
But that growth did not continue in a straight line.
According to the Korean original of Edaily’s report on IBK Investment & Securities’ coverage, revenue fell 22.6% in 2025, from KRW 589.9 billion to KRW 456.3 billion.
By late 2025, however, the numbers began improving again.
The same report describes the recovery as following a brand relaunch, with adjustments to COSRX’s distribution structure and pricing policies. Amorepacific had taken a controlling stake in the company in 2023.
Fourth-quarter revenue reached KRW 152.3 billion, up 10.4% year over year.
Operating profit reached KRW 38.1 billion, up 25.7%.
Double-digit growth then continued through the second quarter of 2026.
The explanation analysts give is important.
Rather than returning to dependence on one global blockbuster line, COSRX has been broadening its SKU mix with newer products and categories.
That is not just a marketing change. It is a change in what the business runs on.
Amorepacific’s own results show where the momentum is
Amorepacific’s first-quarter 2026 results provide another useful clue.
In its official Q1 2026 announcement, the company describes COSRX as a “global derma skincare brand.”
It says COSRX returned to revenue growth as the RX and PDRN lines expanded in North America, supported by strong Amazon promotions.
The same announcement also discusses COSRX growth across EMEA and Japan.
The structure of the release is revealing.
COSRX appears in the North America discussion.
It appears in the EMEA discussion.
It appears again in the Japan and APAC discussion.
It does not appear in the domestic Korea paragraph.
Instead, when Amorepacific highlights a derma brand achieving record Olive Young sales in Korea, the brand it names is AESTURA.
One quarterly earnings release cannot prove that COSRX is unpopular in Korea.
But it is a useful signal about where the parent company sees the brand’s current momentum.
And that signal lines up with the broader revenue picture: COSRX is Korean, but the overwhelming majority of its business is being generated outside Korea.
So, is COSRX actually popular in Korea?
It depends on what you mean by “popular.”
If you mean:
Can you buy COSRX easily in Korea?
Yes.
If you mean:
Do Korean consumers actually use COSRX?
Yes.
The brand has established domestic distribution and years of accumulated Korean consumer reviews.
But if you mean:
Is Korea the market that explains why COSRX became one of the world’s best-known K-beauty brands?
No.
More than 90% of COSRX sales come from overseas, and the company was built with international consumers in mind from the beginning.
That makes COSRX a different case from the other brands I have checked.
When I looked at whether Anua is actually popular in Korea, its international growth sat alongside substantial Korean retail visibility.
With BIOHEAL BOH, the domestic evidence was even more direct: Olive Young’s own sales data showed sustained category strength in lifting and firming skincare.
COSRX sits somewhere else.
It has a genuine Korean customer base, but its scale and much of its cultural weight were built outside Korea — deliberately.
That is a more accurate description than either “Koreans love COSRX” or “Koreans don’t use COSRX.”
What this means if you are shopping for COSRX
There are two practical lessons here.
First, do not automatically treat “K-beauty” and “what Koreans buy” as the same category.
A product does not become less authentically Korean because it sells better in the US or Europe than it does in Korea.
And a product does not automatically become better because it ranks highly in Korea.
These are questions about market position, not product quality.
If the Advanced Snail 96 Mucin Power Essence works well for your skin, there is no reason to stop using it because another COSRX line is currently growing faster.
Popularity is not efficacy.
Second, if you want to understand COSRX in 2026, rather than the version of COSRX that became internationally famous years ago, it makes sense to look at the products driving the company now.
RX, peptides, vitamin C, retinol, PDRN and newer treatment-focused products have become increasingly important to its growth.
That does not erase the Snail line.
It simply means COSRX is no longer economically dependent on the product family that still defines its image for many international shoppers.
COSRX also has a much longer history in toner pads than many overseas consumers realize. If you want to see how that category is competing in Korea now, I broke down the Korean rankings separately in my Korean toner pad guide.
The verdict
So, is COSRX actually popular in Korea?
Yes — but with an asterisk that matters more than usual.
COSRX is not a Korean brand that only foreigners know.
It has been sold and used in Korea for more than a decade, has established domestic distribution and has accumulated a genuine Korean consumer base.
But Korea does not explain the scale of COSRX.
The company was built with overseas markets in mind from the beginning, and that strategy worked so well that more than 90% of its sales now come from outside Korea.
At the same time, COSRX itself has changed.
The Snail line that made the brand famous internationally is no longer its largest line by estimated sales, while newer products are becoming more important growth drivers.
So the most accurate answer is not that COSRX is unpopular in Korea.
It is that COSRX is a Korean brand whose global business became much bigger than its domestic footprint.
That is an important distinction.
And it is exactly why “popular K-beauty” and “what Koreans actually buy” should never automatically be treated as the same thing.
Company figures and market information were checked in September 2026. Revenue mix, retail rankings and product availability can change over time.